Advertisement
Skip to Content

MDxHealth SA MXDHF Stock Quote

| Rating as of

PINX: MXDHF

Last close prices updated as of Jan 04, 2023, 3:59 PM EST | USD
  • Last Close 0.0001
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Investment Style Small Blend
  • Day Range < 0.01  –  < 0.01
  • Year Range < 0.01  –  0.70
  • Market Cap 16,288.0936
  • Volume / Avg 100.0 /  983.0
  • Price / Sales < 0.01
  • Price / Book < 0.01
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis MXDHF

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics MXDHF

Company Profile MXDHF

Business Description

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Contact
Rue d’Abhooz, 31, Cap Business Center, Herstal
Liege, 4040, BEL
Industry Diagnostics & Research
Employees 39

FAQs for MDxHealth SA Stock

No. MXDHF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

MXDHF’s market cap is 16,288.09.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

MXDHF’s stock style is Small Core.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

MXDHF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare MXDHF’s historical performance against its industry peers and the overall market.